Startups channel feed

Big leas­es, big­ger re­grets: Biotech slump turns swanky of­fices from as­set in­to li­a­bil­i­ty

3 days ago
In Focus

Al­tos Labs buys an­ti-ag­ing start­up Do­ri­an Ther­a­peu­tics

4 days ago
Deals

Re­pro­duc­tive health biotech snags $65M to de­vel­op for­mer No­var­tis and Mer­ck KGaA drugs

4 days ago
Financing

UK biotech Ju­ve­nes­cence tar­gets $150M+ for 'healthy lifes­pan' drug can­di­dates

4 days ago
Financing

Ex­clu­sive: Weight loss start­up Cal­i­brate swaps CEOs in lat­est lead­er­ship shake­up

4 days ago
People
Health Tech

Retro Bio­sciences inks blood dis­or­der deal as Sam Alt­man-backed biotech seeks $1B in funds

5 days ago
Deals
Cell/Gene Tx

Ex­clu­sive: Cell­Cen­tric col­lects $120M to treat mul­ti­ple myelo­ma with a cap­sule

5 days ago
Financing

Ap­n­imed posts first set of Phase 3 sleep ap­nea re­sults, aims for ap­proval fil­ing in 2026

6 days ago
R&D

It's been three months with­out a biotech IPO

Last week
Financing

Eli Lil­ly turns to South Ko­re­an RNA edit­ing biotech for hear­ing loss in deal worth $1.3B

Last week
Deals
Cell/Gene Tx

Pathos AI col­lects $365M to fu­el 'bul­let­proof' on­col­o­gy tri­als and in-li­cense more can­cer drugs

Last week
Financing
AI

Ab­b­Vie dou­bles down on siR­NA with $335M up­front bet on ADARx

Last week
Deals
Pharma

Dutch biotech gets $146M for late-stage tri­als in three meta­bol­ic dis­or­ders

Last week
Financing

Ex­clu­sive: Patrick Hsu start­up launch­es, looks be­yond CRISPR for gene in­ser­tion tech­nol­o­gy

Last week
Cell/Gene Tx

Chron­ic care start­up Oma­da Health files to go pub­lic

3 weeks ago
Financing
Health Tech

AI biotech In­sil­i­co Med­i­cine goes for third at­tempt at Hong Kong IPO

3 weeks ago
Financing
AI

HAYA Ther­a­peu­tics gets $65M for 'dark genome' work fol­low­ing last year's Lil­ly pact

3 weeks ago
Financing

Ex­clu­sive: Degra­da­tion start­up rais­es $39M for piv­ot to PRO­TACs and clin­i­cal en­try

3 weeks ago
People
Financing

Sin­ga­pore car­dio gene ther­a­py biotech col­lects $45M as it plots Eu­rope ex­pan­sion

3 weeks ago
Financing
Cell/Gene Tx

Func­tion buys Ezra, cre­at­ing one-stop shop for pre­ven­tive test­ing and scans

3 weeks ago
Deals
Health Tech

Ex­clu­sive: Deer­field se­cures $600M+ for third health­care ven­ture fund to seed new com­pa­nies

3 weeks ago
Financing

Pathos AI gets As­traZeneca fund­ing as biotech plans to raise up to $400M

4 weeks ago
Financing
AI

The in­side sto­ry of how Sali­o­Gen, a start­up try­ing to wran­gle ‘jump­ing genes’ to make med­i­cines, fell apart

4 weeks ago
In Focus

Ar­tios drug ex­ploits ‘repli­ca­tion stress’ in can­cer, shrink­ing sub­set of tu­mors in ear­ly study

4 weeks ago
R&D
1234 Next page Last page
A service from the Financial Times